| Nov 15 |
Halozyme Submits $2.11 Billion Acquisition Offer For Evotec
|
| Nov 15 |
Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid
|
| Nov 15 |
Halozyme bids for Evotec; BeiGene gets a new name
|
| Nov 14 |
Germany’s Evotec Gets Takeover Interest From Halozyme
|
| Nov 14 |
Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction
|
| Nov 14 |
Evotec jumps as Halozyme confirms takeover interest (updated)
|
| Nov 8 |
Here's How Much a $1000 Investment in Halozyme Therapeutics Made 10 Years Ago Would Be Worth Today
|
| Nov 5 |
Looking Into Halozyme Therapeutics's Recent Short Interest
|
| Nov 5 |
Halozyme: Looking For More Growth Following Record Q3 Earnings
|
| Nov 4 |
Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock
|
